The Role of Clinical and Instrumented Outcome Measures in Balance Control of Individuals with Multiple Sclerosis

被引:18
|
作者
Kanekar, Neeta [1 ]
Aruin, Alexander S. [1 ]
机构
[1] Univ Illinois, Dept Phys Therapy, 1919 West Taylor St, Chicago, IL 60612 USA
关键词
D O I
10.1155/2013/190162
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose. The aim of the study was to investigate differences in balance control between individuals with multiple sclerosis (MS) and healthy control subjects using clinical scales and instrumented measures of balance and determine relationships between balance measures, fatigue, and disability levels in individuals with MS with and without a history of falls. Method. Twelve individuals with MS and twelve healthy controls were evaluated using the Berg Balance and Activities-specific Balance Confidence Scales, Modified Clinical Test of Sensory Interaction on Balance, and Limits of Stability Tests as well as Fatigue Severity Scale and Barthel Index. Results. Mildly affected individuals with MS had significant balance performance deficits and poor balance confidence levels (P < 0.05). MS group had higher sway velocities and diminished stability limits (P < 0.05), significant sensory impairments, high fatigue and disability levels (P < 0.05). Sway velocity was a significant predictor of balance performance and the ability to move towards stability limits for the MS group. For the MS-fallers group, those with lower disability levels had faster movement velocities and better balance performance. Conclusion. Implementation of both clinical and instrumented tests of balance is important for the planning and evaluation of treatment outcomes in balance rehabilitation of people with MS.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Disability outcome measures in multiple sclerosis clinical trials: current status and future prospects
    Cohen, Jeffrey A.
    Reingold, Stephen C.
    Polman, Chris H.
    Wolinsky, Jerry S.
    LANCET NEUROLOGY, 2012, 11 (05): : 467 - 476
  • [32] New outcome measures for multiple sclerosis clinical research: The symptom inventory and the performance scales
    Schwartz, C
    Vollmer, T
    Zeng, Q
    NEUROLOGY, 1996, 46 (02) : 4125 - 4125
  • [33] Evaluation of multiple sclerosis disability outcome measures using pooled clinical trial data
    Goldman, Myla D.
    LaRocca, Nicholas G.
    Rudick, Richard A.
    Hudson, Lynn D.
    Chin, Peter S.
    Francis, Gordon S.
    Jacobs, Adam
    Kapoor, Raj
    Matthews, Paul M.
    Mowry, Ellen M.
    Balcer, Laura J.
    Panzara, Michael
    Phillips, Glenn
    Uitdehaag, Bernard M. J.
    Cohen, Jeffrey A.
    NEUROLOGY, 2019, 93 (21) : E1921 - E1931
  • [34] Wrist and ankle activity monitoring correlates with clinical outcome measures in subjects with multiple sclerosis
    Espasandin, M.
    Barber, T.
    Calado-Marta, M.
    Johnston, A.
    Giovannoni, G.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S216 - S216
  • [35] The genetics of clinical outcome in multiple sclerosis
    Ramagopalan, Sreeram V.
    DeLuca, Gabriele C.
    Degenhardt, Alexandra
    Ebers, George C.
    JOURNAL OF NEUROIMMUNOLOGY, 2008, 201 : 183 - 199
  • [36] Is the clinical outcome in multiple sclerosis predictable?
    Confavreux, C
    Grimaud, J
    Vukusic, S
    Moreau, T
    REVUE NEUROLOGIQUE, 1998, 154 (8-9) : 624 - 628
  • [37] Outcome measures assisting treatment optimization in multiple sclerosis
    Pardo, Gabriel
    Coates, Samantha
    Okuda, Darin T.
    JOURNAL OF NEUROLOGY, 2022, 269 (03) : 1282 - 1297
  • [38] The usefulness of evaluative outcome measures in patients with multiple sclerosis
    de Groot, V.
    Beckerman, H.
    Uitdehaag, B. M. J.
    de Vet, H. C. W.
    Lankhorst, G. J.
    Polman, C. H.
    Bouter, L. M.
    BRAIN, 2006, 129 : 2648 - 2659
  • [39] Are static and functional balance abilities related in individuals with Multiple Sclerosis?
    Pau, Massimiliano
    Porta, Micaela
    Coghe, Giancarlo
    Corona, Federica
    PilIoni, Giuseppina
    Lorefice, Lorena
    Marrosu, Maria Giovanna
    Cocco, Eleonora
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2017, 15 : 1 - 6
  • [40] Outcome measures assisting treatment optimization in multiple sclerosis
    Gabriel Pardo
    Samantha Coates
    Darin T. Okuda
    Journal of Neurology, 2022, 269 : 1282 - 1297